Sysfore CB Rank Heat Score
871988
46
Cloud Computing
Enterprise Resource Planning (ERP)
News & Analysis
News Signals
All Recent Activity
All Notable Events
Thursday, May 23, 2024
FiercePharma May 23, 2024
Apellis takes it slow with first Syfovre DTC campaign Wednesday, May 8, 2024
FiercePharma May 8, 2024
Despite ‘robust’ Syfovre growth, concerned Apellis investors sent shares down 10% Wednesday, February 28, 2024
FiercePharma Feb 28, 2024
Apellis cites current challenges with Syfovre launch but bright prospects in the long term Tuesday, December 5, 2023
Monday, November 6, 2023
Fierce Pharma Nov 6, 2023
Apellis parries Astellas' long-term Izervay data with 3-year results on its rival GA med Syfovre Friday, October 6, 2023
Endpoints News Oct 6, 2023
Apellis’ Syfovre on the comeback trail from vasculitis worries after $74M in initial Q3 sales Thursday, October 5, 2023
Fierce Pharma Oct 5, 2023
Apellis' stumbling GA drug Syfovre shows signs of recovery SeekingAlpha Oct 5, 2023
Apellis updates number of retinal vasculitis cases among Syfovre users SeekingAlpha Oct 5, 2023
Apellis reports preliminary U.S. net revenues of about $74M for SYFOVRE in Q3 Tuesday, August 29, 2023
Investing.com Aug 29, 2023
Apellis Pharmaceuticals announces plan to slash workforce by 25% 
© 2026 Crunchbase Inc. All Rights Reserved.